Advertisement

Topics

Pro-Trader Daily: Featured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season

08:21 EDT 19 Jun 2017 | FinanzNachrichten

LONDON, UK / ACCESSWIRE / June 19, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Lannett Co., Inc. (NYSE: LCI). The Company announced on June...

Original Article: Pro-Trader Daily: Featured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season

NEXT ARTICLE

More From BioPortfolio on "Pro-Trader Daily: Featured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season"

Advertisement
Quick Search
Advertisement
Advertisement